To date, HIF-1α over-expression is reported in various cancer lines, where it facilitates metastasis, tumor progression, and resistance to anticancer drugs [29,30]; however, to our knowledge, there is almost no data about the metabolic phenotype of ‘HIF-1α-positive’ mammals. Here, HIF1A is linked to cancer.